Senores Pharmaceuticals Approves Re-Appointment of Managing Director and Whole-Time Director
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 13 Oct 2026, 5:48 pm
Senores Pharmaceuticals Approves Re-Appointment of Managing Director and Whole-Time Director The Board of Directors of Senores Pharmaceuticals Limited approved the re-appointment of Mr. Swapnil Jatinbhai Shah as Managing Director for a three-year term effective 15th Oct'26, liable to retire by rotation. Additionally, the Board approved the re-appointment of Mr. Chetan Bipinchandra Shah as Whole Time Director for three consecutive years effective 10th Nov'26, also liable to retire by rotation. Both key leadership appointments remain subject to shareholder approval via a postal ballot process.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
